[1]华启洋,吴同利,刘永艳,等.幽门螺杆菌在胃食管反流病发病中的作用[J].医学信息,2019,32(20):103-104,107.[doi:10.3969/j.issn.1006-1959.2019.20.029]
　HUA Qi-yang,WU Tong-li,LIU Yong-yan,et al.The Role of Helicobacter Pylori in the Pathogenesis of Gastroesophageal Reflux Disease[J].Journal of Medical Information,2019,32(20):103-104,107.[doi:10.3969/j.issn.1006-1959.2019.20.029]
点击复制

幽门螺杆菌在胃食管反流病发病中的作用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年20期
页码:
103-104,107
栏目:
临床研究
出版日期:
2019-10-15

文章信息/Info

Title:
The Role of Helicobacter Pylori in the Pathogenesis of Gastroesophageal Reflux Disease
文章编号:
1006-1959（2019）20-0103-03
作者:
华启洋; 吴同利; 刘永艳; 孙凤芹; 姚 燕
（昆山市第四人民医院消化科，江苏 昆山 215331）
Author(s):
HUA Qi-yang; WU Tong-li; LIU Yong-yan; SUN Feng-qin; YAO Yan
(Department of Gastroenterology,Kunshan Fourth People's Hospital,Kunshan 215331,Jiangsu,China)
关键词:
胃食管反流病; 幽门螺杆菌; 慢性胃炎
Keywords:
Gastroesophageal reflux disease; Helicobacter pylori; Chronic gastritis
分类号:
R573
DOI:
10.3969/j.issn.1006-1959.2019.20.029
文献标志码:
A
摘要:
目的 探讨幽门螺杆菌（Hp）在胃食管反流病（GERD）发病中的作用，为临床诊治GERD提供参考。方法 选取2016年 2月~2018年12月我院收治的胃食管反流病患者85例，设为GERD组，另选同期我院体检健康者30人为对照组，14C呼气试验法进行Hp检测，比较两组Hp感染阳性率、GERD不同症状程度者Hp感染阳性率以及反流性食管炎（RE）不同程度者Hp感染阳性率。结果 GERD组Hp感染阳性率（54.12%）高于对照组（46.67%），差异无统计学意义（P＞0.05）；GERD轻度症状组、中度症状组、重度症状组及极重度症状组Hp感染阳性率分别为55.00%、52.00%、54.55%、55.56%，组间比较，差异无统计学意义（P＞0.05）；RE患者LA-A组、LA-B组、LA-C组及LA-D组Hp感染阳性率分别是57.14%、55.56%、47.06%、46.15%，组间比较差异无统计学意义（P＞0.05）。结论 幽门螺杆菌感染在胃食管反流病发生和发展过程中可能无相关性，但对于Hp阳性的GERD患者也应根据实际情况实施根除Hp治疗，以减少恶变几率。
Abstract:
Objective To investigate the role of Helicobacter pylori (Hp) in the pathogenesis of gastroesophageal reflux disease (GERD) and provide reference for clinical diagnosis and treatment of GERD.Methods 85 patients with gastroesophageal reflux disease admitted to our hospital from February 2016 to December 2018 were enrolled in the GERD group. Another 30 healthy people in our hospital were selected as the control group, and the 14C breath test method was used for Hp detection. The positive rate of Hp infection, the positive rate of Hp infection in different degrees of GERD, and the positive Hp infection in different degrees of RE were compared between the two groups.Results The positive rate of Hp infection in GERD group (54.12%) was higher than that in control group (46.67%), the difference was not statistically significant (P>0.05); GERD mild symptom group, moderate symptom group, severe symptom group and very severe symptom group Hp the positive rates of infection were 55.00%, 52.00%, 54.55%, and 55.56%, respectively. There was no significant difference between the groups (P>0.05).The positive rates of Hp infection in LA-A group, LA-B group, LA-C group and LA-D group were 57.14%, 55.56%, 47.06%, and 46.15%, respectively. There was no significant difference between the groups (P>0.05).Conclusion Helicobacter pylori infection may not be associated with the development and progression of gastroesophageal reflux disease. However, patients with Hp-positive GERD should also be treated with Hp eradication according to the actual situation to reduce the risk of malignant transformation.

参考文献/References:

[1]刘东振.幽门螺杆菌相关性疾病及根除治疗现状与进展[J].医学理论与实践,2013,26(22):2969-2971. [2]Hong SJ,Kim SW.Helicobacter pylori Infection in Gastroesophageal Reflux Disease in the Asian Countries[J].Gastroenterol Res Pract,2015(2015):985249. [3]郭薇薇,陈玲,缪鑫,等.幽门螺杆菌对胃食管反流病影响的Meta分析[J].胃肠病学和肝病学杂志,2017,26(10):1133-1137. [4]Rahim M,Eskandar H,Koorosh M,et al.Hpylori infection and reflux esophagitis:Aease-control study[J].World Journal of Gastroenterol,2016,12(35):5658-5662． [5]李晓芳,徐俊荣.胃食管反流病与幽门螺杆菌的相关性分析[J].山西医药杂志,2016,45(23):2783-2785. [6]王霄腾,张梦,陈超英,等.根除幽门螺杆菌与胃食管反流病关系的Meta分析[J].中华内科杂志,2016,55(9):710-716. [7]Kim LK,Looser P,Swaminathan RV,et al.Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus[J].Gastroenterology,2013,145(6):1237-1244. [8]Ronkainen J,Agréus L.Epidemiology of reflux symptoms and GORD.[J].Best Pract Res Clin Gastroenterol,2013,27(3):325-337. [9]Emerenziani S,Rescio MP,Guarino MP,et al.Gastro-esophageal reflux disease and obesity, where is the link?[J].World J Gastroenterol,2013,19(39):6536-6539.

相似文献/References:

[1]郭绍敏.克拉霉素四联方案对一线方案根除失败的幽门螺杆菌的再根除效果评估[J].医学信息,2018,31(02):121.[doi:10.3969/j.issn.1006-1959.2018.02.044]
　GUO Shao-min.Evaluation of the Re-eradication Effect of Clarithromycin Quadruple Regimen on Helicobacter Pylori Eradication Failure in the First Line Scheme[J].Journal of Medical Information,2018,31(20):121.[doi:10.3969/j.issn.1006-1959.2018.02.044]
[2]罗宜辉,刘代华.益生菌联合四联方案根除幽门螺杆菌的临床研究[J].医学信息,2018,31(11):25.[doi:10.3969/j.issn.1006-1959.2018.11.008]
　LUO Yi-hui,LIU Dai-hua.Clinical Study on the Eradication of Helicobacter Pylori by Probiotics Combined with Quadruple Regimen[J].Journal of Medical Information,2018,31(20):25.[doi:10.3969/j.issn.1006-1959.2018.11.008]
[3]马艳会,寇 毅.幽门螺杆菌感染与结直肠腺瘤临床特征的相关性研究[J].医学信息,2022,35(16):102.[doi:10.3969/j.issn.1006-1959.2022.16.024]
　MA Yan-hui,KOU Yi.Correlation Between Helicobacter Pylori Infection and Clinical Features of Colorectal Adenoma[J].Journal of Medical Information,2022,35(20):102.[doi:10.3969/j.issn.1006-1959.2022.16.024]
[4]陶源,徐俊林,张艳,等.上消化道黏膜病变病理诊断结果分析[J].医学信息,2020,33(02):125.[doi:10.3969/j.issn.1006-1959.2020.02.036]
　TAO Yuan,XU Jun-lin,ZHANG Yan,et al.Analysis of Pathological Diagnosis for Upper Gastrointestinal Mucosal Lesions[J].Journal of Medical Information,2020,33(20):125.[doi:10.3969/j.issn.1006-1959.2020.02.036]
[5]周 政.胃息肉与幽门螺杆菌感染的关系[J].医学信息,2021,34(21):91.[doi:10.3969/j.issn.1006-1959.2021.21.023]
　ZHOU Zheng.Relationship Between Gastric Polyps and Helicobacter Pylori Infection[J].Journal of Medical Information,2021,34(20):91.[doi:10.3969/j.issn.1006-1959.2021.21.023]
[6]黄 飞.不同用药方案治疗幽门螺杆菌感染胃溃疡的效果比较[J].医学信息,2020,33(16):156.[doi:10.3969/j.issn.1006-1959.2020.16.050]
　HUANG Fei.Comparison of the Effects of Different Medication Regimens in the Treatment of Gastric Ulcer Infected by Helicobacter Pylori[J].Journal of Medical Information,2020,33(20):156.[doi:10.3969/j.issn.1006-1959.2020.16.050]
[7]王蓓蓓,白 梅.黄芪建中汤加减联合四联疗法对Hp阳性胃溃疡患者Hp清除率及复发率的影响[J].医学信息,2022,35(20):145.[doi:10.3969/j.issn.1006-1959.2022.20.040]
　WANG Bei-bei,BAI Mei.Effect of Huangqi Jianzhong Decoction Combined with Quadruple Therapy on Hp Clearance Rate and Recurrence Rate in Patients with Hp Positive Gastric Ulcer[J].Journal of Medical Information,2022,35(20):145.[doi:10.3969/j.issn.1006-1959.2022.20.040]
[8]张 静,张鸿博.中医药治疗幽门螺杆菌相关性胃溃疡研究[J].医学信息,2022,35(20):173.[doi:10.3969/j.issn.1006-1959.2022.20.048]
　ZHANG Jing,ZHANG Hong-bo.Study on Traditional Chinese Medicine Treatment of Helicobacter Pylori Associated Gastric Ulcer[J].Journal of Medical Information,2022,35(20):173.[doi:10.3969/j.issn.1006-1959.2022.20.048]
[9]张运林.铝碳酸镁片联合雷贝拉唑Hp感染合并活动性消化性溃疡的安全性[J].医学信息,2020,33(24):125.[doi:10.3969/j.issn.1006-1959.2020.24.035]
　ZHANG Yun-lin.The Safety of Hydrotalcite Tablets Combined with Rabeprazole Hp Infection with Active Peptic Ulcer[J].Journal of Medical Information,2020,33(20):125.[doi:10.3969/j.issn.1006-1959.2020.24.035]
[10]朱 颖,李国栋,王 伟,等.泮托拉唑与奥美拉唑治疗Hp阳性十二指肠溃疡有效性及安全性的Meta分析[J].医学信息,2023,36(02):74.[doi:10.3969/j.issn.1006-1959.2023.02.015]
　ZHU Ying,LI Guo-dong,WANG Wei,et al.Meta-analysis of the Efficacy and Safety of Pantoprazole and Omeprazole in the Treatment of Hp-positive Duodenal Ulcer[J].Journal of Medical Information,2023,36(20):74.[doi:10.3969/j.issn.1006-1959.2023.02.015]

更新日期/Last Update: 2019-10-15